Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.47−0.04 (-2.69%)
Close on Nov 19, 2026Market cap $1.92MP/E –Yield –
Can-Fite BioPharma gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Can-Fite BioPharma
Can-Fite BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?